Increased Chamber Resting Tone Is a Key Determinant of Left Ventricular Diastolic Dysfunction.

Authors:
Tamargo M; Martínez-Legazpi P; Espinosa MÁ; Lyon A; Méndez I and 14 more

Journal:
Circ Heart Fail

Publication Year: 2023

DOI:
10.1161/CIRCHEARTFAILURE.123.010673

PMCID:
PMC10729900

PMID:
38113298

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Circ Heart Fail

Abbreviation: Circ Heart Fail

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Vascular Diseases

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Proteomic Associations of NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide) in Heart Failure Wi…
Azzo JD; Dib MJ; Zagkos L and 21 more (2024) - Transparency Score: 3/6
Propensity-Matched Study of Early Cardiac Rehabilitation in Patients With Acute Decompensated Heart…
Enzan N; Matsushima S; Kaku H and 8 more (2023) - Transparency Score: 3/6
Urinary cGMP (Cyclic Guanosine Monophosphate)/BNP (B-Type Natriuretic Peptide) Ratio, Sacubitril/Va…
Butt JH; Ibrahim W; Dewan P and 10 more (2023) - Transparency Score: 4/6
Use of a Cardiac Scale to Predict Heart Failure Events: Design of SCALE-HF 1.
Fudim M; Yazdi D; Egolum U and 10 more (2023) - Transparency Score: 4/6
Use of a Pulmonary Artery Pressure Sensor to Manage Patients With Left Ventricular Assist Devices.
Thohan V; Abraham J; Burdorf A and 13 more (2023) - Transparency Score: 4/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Disclosures None."

Evidence found in paper:

"Sources of Funding This study was supported by grant PI15/02229 from the Instituto de Salud Carlos III, Spain. Dr Tamargo was partially supported by grants from the Fundación para la Investigación Biomédica Gregorio Marañón, Spain, and CM20/00054 from the Instituto de Salud Carlos III, Spain. The latter and CIBERCV are co-financed by the European Development Regional Fund “A Way to Achieve Europe” (EDRF). In addition, the work was supported by the Netherlands Organization for Scientific Research (NWO-ZonMw, VIDI grant 016.176.340 to Dr Lumens)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025